THE RELEASE of certain tissue enzymes into the blood has been useful in the diagnosis of a number of diseases and in monitoring patients during therapy (1). Collagen proline hydroxylase is present as an intracellular enzyme in all tissues producing collagen. Since solid tumors produce collagen, it was of interest to determine enzyme levels in a number of tumors and to find whether, during the growth of enzyme-rich tumors, collagen proline hydroxylase was released into the blood.
THE RELEASE of certain tissue enzymes into the blood has been useful in the diagnosis of a number of diseases and in monitoring patients during therapy (1) . Collagen proline hydroxylase is present as an intracellular enzyme in all tissues producing collagen. Since solid tumors produce collagen, it was of interest to determine enzyme levels in a number of tumors and to find whether, during the growth of enzyme-rich tumors, collagen proline hydroxylase was released into the blood.
MATERIALS AND METHODS
Tumor-bearing mice were maintained by subcutaneous transplantation of the following lines: BWlO139, a rhabdomyosarcoma (without cross striations) in CEIJ males; SaD 2 , a fibrosarcoma in DBA/2J males; DC II, a chondrosarcoma in BALB/cAnN males.
Tumor-bearing rats were maintained by subcutaneous transplantation of a subline of hepatoma 5123C and chondrosarcoma in Buff/MAl males. Guinea pig granulomas were induced by carrageenan as described previously (2) .
The BWlOl39 and the SaD 2 mouse sarcomas and normal host animals were obtained from The Jackson Laboratory, Bar Harbor, Maine. The DC II mouse chondrosarcoma, the ra t hepatoma 5123C, and the rat chondrosarcoma were supplied by Dr. R. Swarm, Hoffmann-La Roche Inc., Nutley, New Jersey.
Tumor tissue or skin was excised and extracts for enzyme assay were prepared by homogenization in 2 volumes of 0.25 M sucrose contammg 0.01 M Tris-Cl, pH 7.2, 0.0015 M MgCI 2 , 0.01 M KCl, and 0.005% phenylmethyl sulfonyl fluoride at OOC in a glass tube with a Teflon pesde (Potter-Elvehjem). As many strokes were used as were necessary to get about 80-90% cell breakage. The homogenate was spun at 27,000 X g for 20 minutes, and the supernatant, designated S-27 fraction, was decanted and made 0.1 mM with respect to dithiothreitol and 0.01 mM to ethylenediamine-tetraacetic acid (EDTA). The S-27 fractions were immediately shell frozen and stored at -28°C until they were assayed for proline hydroxylase.
Serum samples were obtained from blood collected from the vena cava of animals anesthetized with chloral hydrate (OA ml of a 3% solution in 0.154 M NaCI per mouse). The blood from each animal was allowed to coagulate for 30 minutes at room temperature. Mter contraction of the clot for 3 hours at 6°C, the serum was removed (0.1-0.4 ml from each animal). Sera from several animals were pooled. All subsequent steps were carried out at O°C. To concentrate enzyme activity, 1.0 ml samples of serum (those of less than 1.0 ml were adjusted to 1.0 ml volume by addition of an appropriate volume of normal saline) were transferred to tubes, and 0.02 ml of a solution containing 1.0 mM dithiothreitol and 0.1 mM EDTA were added. An equal volume of saturated ammonium sulfate was then added dropwise. The mixture was stirred for 20 minutes and centrifuged at 27,000 X g for 20 minutes. The precipitates were dissolved by gende agitation for 10 minutes in 0.25 ml of freshly prepared 0.05 M sodium cacodylate buffer, pH 7.0, containing 0.1 mM dithiothreitol and 0.01 mM EDTA.
Enzyme activity in tumor extracts and serum concentra tes was determined by the method of Hutton et al. (3) . Tritium-labeled substrate of peptidyl proline 3 was used, and the assay depended on release of tritium from carbon four of proline by the entering hydroxyl group. The enzymatic reaction was carried out in a 1.0 ml volume containing: 3H-prolyl peptides from guinea pig granuloma, 50 JLmoles of Tris-Cl, pH 7.2, 0.5 JLmole of ascorbic acid, 0.1 JLmole of ferrous ammonium sulfate, 1.0 JLmole of a-ketoglutaric acid, 1-2 mg of heatdenatured bovine albumin, and the enzyme source. After incubation, tritiated water was distilled from the mixture, 0.8 ml was mixed with 10 ml of Bray's solution (5), and radioactivity was measured in a scintillation spectrometer. Incubations were for 30 minutes. Activities were reported either as cpm/g of tissue or as nanomoles of hydroxyproline (Hyp) formed per g of tissue or per ml of serum. Tritium counts were converted to nanomoles of hydroxyproline by simultaneous analyses made with tritium-labeled substrate and a-ketoglutarate-1_14C of known specific activity and measurement of the 14C0 2 evolved, as described by Rhoads and Udenfriend (6) . In this study, 4230 cpm of 3H 2 0 were released from the tritium-labeled substrate per nanomole of hydroxyproline formed.
RESULTS
The activity of collagen proline hydroxylase of different tissues and tumors is shown in table 1. Three mouse sarcomas were among the most active tissues. The high activity of these mouse tumors and their rapid growth rates made them the most desirable for the following studies. "Tissues were homogenized, and samples of the 8·27 fractions were taken for assay. Activities are reported in terms of tritium released as tritiated water when hydroxyproline is formed (see "Materials and Methods") per g of tissue.
Serum Levels of Collagen Proline Hydroxylase in Normal Mice
. .
When sera from control mice were assayed, activities ranged from 0.009-0.054 nanomole hydroxyproline/m!. To show that the tritium released by normal serum extracts truly represented activity of collagen proline hydroxylase, incubations were carried aut with and without a-ketoglutarate, an absolutely specific and unique cosubstrate of this enzyme (7) . As shown in table 2, a-ketoglutarate was required for activity, an indication that normal mouse serum contains small but measurable amounts of collagen proline hydroxylase.
Known amounts of collagen proline hydroxylase prepared from the skins of newborn rats (8) were ad.ded to samples of mouse serum and carried through the procedure of concentration and assay. The results of one such experiment, table 2, indicate that the added activity can be recovered quantitatively after concentration. Recoveries of enzyme added to sera from host and tumor-bearing animals were run as controls. These ranged from 80-100%.
Serum Levels of Collagen Proline Hydroxylase in Mice Implanted With Sarcomas
Three mouse sarcomas containing high amounts of collagen proline hydroxylase (see table I) were implanted in the strain of mouse used to carry the tumor. After a given time the animals were killed and specimens of tumor and serum were assayed for enzyme activity. Sera of untreated animals were assayed at the same time as controls. As shown in table 3, serum enzyme levels were increased markedly in each group with implanted tumors. This increase in activity for the tumor-implanted animals was further identified as collagen proline hydroxylase by showing an absolute requirement for a-ketoglutarate (table 4) which is characteristic for this enzyme. ·Enzyme activity was measured in the entire S·27 fraction prepared as described in "Materials and Methods." This value was converted to activity per total tumor mass.
tSera from 5-12 mice (depending on amount collected per mouse) were pooled and serum concentrates prepared from 1.0 mI of each pool for enzyme assay as described In "Materials and Methods." The results are expressed as averages of the concentrates of the number of pools Indicated. Since the total serum volume of the mouse Is 0.!l-1.0 mI, these values represent the approximate total serum enzyme per mouse. In each case, the tumors had nearly reached maximal weight. The serum enzyme activity was significantly higher In the tumor-bearing animals than in the control animals (P values <0.005).
tOne unit = one nanomole of hydroxyproline formed per 30 minutes = 4230 cpm.
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Serum Levels of Collagen Proline Hydroxylase at DiFferent Times During Tumor Growth
To correlate the appearance of serum enzyme activity with tumor growth, mice with the DC II chondrosarcoma were bled 10, 20, 26, 34, and 45 days after receiving tumor transplants. On some days sera were obtained from normal littermates as controls. When the tumors were large enough for extracts to be made, some animals were killed and the tumor tissue was assayed for enzyme activity. The results of this experiment, shown in text-figure 1, indicate that the increase in serum enzyme levels parallels that in the growing tumors. The serum levels of control animals, measured at days 20, 34, and 45 (hatched bars) did not rise above the zero-day values of 0.01 nanomole of hydroxyproline/mi. Although the tumors enlarged beyond day 26, there was little increase in their collagen proline hydroxylase activity. This was no doubt due to the greater degree of necrosis at the later stages of tumor growth.
DISCUSSION
The formation of collagen involves certain enzymatic steps uniquely related to the biosynthesis of this structural protein. These include intracellular enzymes hydroxylating certain proline or lysine residues on growing or completed polypeptide chains. Recent advances in the characterization and assay of collagen proline hydroXylase make it possible to detect and assay this enzyme in most animal tissues. Activity of collagen proline hydroxyl- TEXT-FIGURE I.-Activity of collagen proline hydroxylase in solid tumors and blood of mice after implantation of a chondrosarcoma. The chondrosarcoma (DC II) was implanted subcutaneously in 50 mice which were then bled in groups of 10 on 10, 20, 26, 34, and 45 days after the implants. a) Sera from each group of 10 animals and of controls were pooled and 1.0 ml samples were assayed. Each value represented the average of duplicate samples from 2 pools of sera from 10 mice and is reported as enzyme activity per I ml of serum. b) An S-27 fraction was prepared from a small, representative amount of tumor tissue from I animal on each indicated day, except day 10 when the total tumor mass from 4 animals was pooled to make the S-27 fraction. Samples of the S-27 fractions were assayed as described in "Materials and Methods," and the values were converted to actlvltles per total tumor mass by multiplication by the average tumor weight on each day [ ].
ase has been used to follow collagen biosynthesis in wound repair (9), liver fibrosis (10), and fibroblasts in tissue culture (J 1) . The present studies demonstrate that activity of collagen proline hydroxylase is present in'lfmall amounts in normal adult mouse serum. Increased amounts of collagen proline hydroxylase are detectable in the sera of animals with certain collagenproducing tumors. Furthermore, the amount of enzyme activity in the total serum volume is as much as 0.1-0.2% of that in the entire tumor when the tumor is one-tenth its final stage of growth (terminus) .
Our initial attempts to demonstrate proline hydroxylase in normal sera from animals other than JOURNAL OF THE NATIONAL CANCER INSTITUTE the mouse were not successful. This may be due to low levels of enzyme or to inhibitors of the enzyme in the sera of those species tested. Also, the enzyme possibly deteriorates during the clotting of blood. Procedures for increasing the sensitivity of the assay and making it applicable to sera and plasma of other animals, including man, are being investigated. Such methods may be used to follow the progress of patients with metastasizing collagenproducing tumors and to diagnose, differentially, tumors of uncertain origin. Similarly, the serum level of collagen proline hydroxylase may be of diagnostic and prognostic value in other human diseases 4 characterized by excessive collagen production, e.g., hepatic cirrhosis and pneumoconiosis.
